Showing results (1641-1650 of 2,222) with videos related to

Sort By:
Pageof 223
Free Radical Biology & Medicine|June 27, 2012
Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cellsQingning Bian, Shasha Gao, Jilin Zhou, et al.
Aging|June 21, 2020
Biomarkers of aging and lung function in the normative aging studyCuicui Wang, Allan Just, Jonathan Heiss, et al.
Journal of the American College of Nutrition|April 7, 2010
The impact of weight normalization on quality of recovery in anorexia nervosaCéline Meguerditchian, Catherine Samuelian-Massat, René Valéro, et al.
Neuromuscular Disorders : NMD|May 11, 2010
Drosophila indirect flight muscle specific Act88F actin mutants as a model system for studying congenital myopathies of the human ACTA1 skeletal muscle actin geneSarah E Haigh, Sheetal S Salvi, Maria Sevdali, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 8, 2010
Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapibLaurent Yvan-Charvet, Jelena Kling, Tamara Pagler, et al.
The EMBO Journal|September 16, 1999
MEF-2 function is modified by a novel co-repressor, MITRD B Sparrow, E A Miska, E Langley, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2006
SAR studies: designing potent and selective LXR agonistsJason W Szewczyk, Shaei Huang, Jayne Chin, et al.
Eye (London, England)|February 9, 2008
The Cataract National Dataset electronic multicentre audit of 55,567 operations: antiplatelet and anticoagulant medicationsJ D Benzimra, R L Johnston, P Jaycock, et al.
Frontiers in Physiology|December 30, 2024
Nutraceuticals silybin B, resveratrol, and epigallocatechin-3 gallate-bind to cardiac muscle troponin to restore the loss of lusitropy caused by cardiomyopathy mutations in vitro, in vivo, and in silicoZeyu Yang, Alice M Sheehan, Andrew E Messer, et al.
Journal of Clinical Medicine|October 27, 2022
Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease-Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous BiologicsRobert D Little, Mark G Ward, Emily Wright, et al.
Pageof 223